Harfst & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-100
| Closed | -$5K | – | 98 |
|
|
2017
Q2 | $5K | Sell |
100
-4,957
| -98% | -$248K | ﹤0.01% | 210 |
|
|
2017
Q1 | $275K | Sell |
5,057
-115
| -2% | -$6.25K | 0.12% | 53 |
|
|
2016
Q4 | $302K | Buy |
5,172
+244
| +5% | +$14.2K | 0.15% | 48 |
|
|
2016
Q3 | $265K | Sell |
4,928
-31,820
| -87% | -$1.71M | 0.14% | 57 |
|
|
2016
Q2 | $2.7M | Buy |
36,748
+32,536
| +772% | +$2.39M | 1.09% | 11 |
|
|
2016
Q1 | $269K | Sell |
4,212
-31,720
| -88% | -$2.03M | 0.17% | 58 |
|
|
2015
Q4 | $2.47M | Buy |
35,932
+30
| +0.1% | +$2.06K | 1.01% | 14 |
|
|
2015
Q3 | $2.13M | Buy |
35,902
+33,448
| +1,363% | +$1.98M | 0.93% | 16 |
|
|
2015
Q2 | $163K | Buy |
+2,454
| New | +$163K | 0.09% | 88 |
|